Stefan T. Sigurdsson

Reykjavik, Iceland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Diagnostic plasma protein signatures in sporadic and BRCA1/2 breast cancer patients via targeted proteomics.

Diagnostic plasma protein signatures in sporadic and BRCA1/2 breast cancer patients via targeted proteomics.

Journal: Breast cancer research : BCR
Published: March 13, 2026

MITF maintains genome stability in nonmelanocyte lineages.

MITF maintains genome stability in nonmelanocyte lineages.

Journal: Molecular oncology
Published: October 22, 2025

A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription.

A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription.

Journal: Nature communications
Published: April 29, 2025

Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients.

Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients.

Journal: NPJ breast cancer
Published: May 26, 2023

MicroRNA-190b Targets RFWD3 in Estrogen Receptor-Positive Breast Cancer.

MicroRNA-190b Targets RFWD3 in Estrogen Receptor-Positive Breast Cancer.

Journal: Breast cancer : basic and clinical research
Published: July 15, 2022

Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status.

Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status.

Journal: British journal of cancer
Published: March 09, 2020

CpG promoter hypo-methylation and up-regulation of microRNA-190b in hormone receptor-positive breast cancer.

CpG promoter hypo-methylation and up-regulation of microRNA-190b in hormone receptor-positive breast cancer.

Journal: Oncotarget
Published: May 11, 2019

BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy.

BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy.

Journal: JNCI cancer spectrum
Published: March 12, 2019

Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer.

Epigenetic inactivation of the splicing RNA-binding protein CELF2 in human breast cancer.

Journal: Oncogene
Published: December 27, 2018

Northern lights assay: a versatile method for comprehensive detection of DNA damage.

Northern lights assay: a versatile method for comprehensive detection of DNA damage.

Journal: Nucleic acids research
Published: February 01, 2018

Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin.

Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin.

Journal: Journal of the National Cancer Institute
Published: August 22, 2017

CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.

CpG promoter methylation of the ALKBH3 alkylation repair gene in breast cancer.

Journal: BMC cancer
Published: September 13, 2016
Showing 1-12 of 12

Last Updated: 09/26/2026